Get started
000

DAEWOONG PHARMACEUTICAL

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Forecast Seasonals

069620 chart


Full chart

069620 upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪1.68 T‬ KRW
Dividend yield (indicated)
0.40%
Price to earnings Ratio (TTM)
0
Basic EPS (TTM)
7,900 KRW
Net income (FY)
‪121.74 B‬ KRW
Revenue (FY)
‪1.38 T‬ KRW
Shares float
‪4.35 M‬
Beta (1Y)
0.86

About DAEWOONG PHARMACEUTICAL


Sector
Health Technology
Headquarters
Hwaseong-si
Founded
2002
Website
daewoong.co.kr
ISIN
KR7069620003
FIGI
BBG000C8L291
Daewoong Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceuticals. Its products include general drugs, prescription drugs, health foods, medical devices, quasi drugs, and cosmetics. The company was founded on October 1, 2002 and is headquartered in Hwaseong-si, South Korea.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

069620 news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 069620 is 151,700 KRW — it has decreased by −0.20% in the past 24 hours. Watch DAEWOONG PHARMACEUTICAL stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange DAEWOONG PHARMACEUTICAL stocks are traded under the ticker 069620.
069620 stock has fallen by −3.44% compared to the previous week, the month change is a 9.37% rise, over the last year DAEWOONG PHARMACEUTICAL has showed a 40.33% increase.
We've gathered analysts' opinions on DAEWOONG PHARMACEUTICAL future price: according to them, 069620 price has a max estimate of 220,000.00 KRW and a min estimate of 17,500.00 KRW. Watch 069620 chart and read a more detailed DAEWOONG PHARMACEUTICAL stock forecast: see what analysts think of DAEWOONG PHARMACEUTICAL and suggest that you do with its stocks.
069620 reached its all-time high on Dec 22, 2020 with the price of 286,500 KRW, and its all-time low was 14,500 KRW and was reached on Jun 15, 2004. View more price dynamics on 069620 chart.
See other stocks reaching their highest and lowest prices.
069620 stock is 2.19% volatile and has beta coefficient of 0.86. Track DAEWOONG PHARMACEUTICAL stock price on the chart and check out the list of the most volatile stocks — is DAEWOONG PHARMACEUTICAL there?
Today DAEWOONG PHARMACEUTICAL has the market capitalization of ‪1.75 T‬, it has decreased by −2.86% over the last week.
Yes, you can track DAEWOONG PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
DAEWOONG PHARMACEUTICAL is going to release the next earnings report on Nov 13, 2024. Keep track of upcoming events with our Earnings Calendar.
DAEWOONG PHARMACEUTICAL revenue for the last quarter amounts to ‪343.00 B‬ KRW, despite the estimated figure of ‪331.20 B‬ KRW. In the next quarter, revenue is expected to reach ‪337.58 B‬ KRW.
069620 net income for the last quarter is ‪1.14 B‬ KRW, while the quarter before that showed ‪8.14 B‬ KRW of net income which accounts for −86.00% change. Track more DAEWOONG PHARMACEUTICAL financial stats to get the full picture.
Yes, 069620 dividends are paid annually. The last dividend per share was 600.00 KRW. As of today, Dividend Yield (TTM)% is 0.40%. Tracking DAEWOONG PHARMACEUTICAL dividends might help you take more informed decisions.
DAEWOONG PHARMACEUTICAL dividend yield was 0.51% in 2023, and payout ratio reached 5.63%. The year before the numbers were 0.38% and 15.72% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DAEWOONG PHARMACEUTICAL EBITDA is ‪175.98 B‬ KRW, and current EBITDA margin is 11.91%. See more stats in DAEWOONG PHARMACEUTICAL financial statements.
Like other stocks, 069620 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DAEWOONG PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DAEWOONG PHARMACEUTICAL technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DAEWOONG PHARMACEUTICAL stock shows the buy signal. See more of DAEWOONG PHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.